A high-throughput platform for the non-invasive intracellular delivery of molecules for therapeutic applications
- WO2020257746Isolating live cells after high-throughput, long-term, time-lapse microscopy
A natural beta interferon-inducing therapeutic glycolipid from the microbiome that prevents and treats severe viral infection
- WO2021257494Methods for modulating TLR4 signaling
A novel biologic and therapeutic target for the treatment of diabetes
- WO2020061591Secreted protein that affects blood glucose levels
Application of the SPLANDID antigen presentation technology to HIV-1 vaccine development
- WO2020139963Membrane protein nanoparticles for antigen presentation
Assessment of targeted protein degradation as a strategy for potent antivirals with high barriers to resistance
- WO2020069125Degraders of Hepatitus C Virus NS3/4A Protein
Building better screens and identifying ligands for human MS4A proteins
- WO2017143036Identification of the MS4A family as ligand-gated ion channels
Computationally designed therapy targeting lysosomal function and inflammation in neurodegenerative diseases
- WO2020191212Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases
- WO2023107531Antisense oligonnucleotide drug targets
Developing novel therapeutic approaches for CNS drug delivery by targeting a newly identified key regulator of the blood brain barrier
- WO2014205338Methods and compositions relating to modulation of the permeability of the blood brain barrier
- WO2022155410Structure and mechanisms of the blood-brain barrier DHA transporter Mfsd2a
- WO2023225249Methods and compositions relating to treatment of CNS diseases
Development of AAV-mediated mini-gene therapy for Usher syndrome type 1F, a combined deafness and blindness
- WO2020219990Mini-PCDH15 for treatment of deafness and blindness
Development of an inexpensive at-home influenza kit and detection technology
- WO2021195023Enhancement of RT-RPA reaction by the addition of RNaseH
- WO2021202158Development of an inexpensive at-home influenza
Development of small molecule modulators of autophagy and ER stress as novel therapeutics for AD
- WO2021257697Compounds and methods for blocking apoptosis and inducing autophagy
Development of synthetic analogs of a sleeve gastrectomy-induced metabolite as a novel therapy for type 2 diabetes and obesity
- WO2020041673Compositions and methods related to cholic acid 7-sulfate as a treatment for diabetes
- WO2021226447Methods for inducing bile acid sulfotransferase SULT2A for treating metabolic disorders
- WO2020117945Synthetic derivatives of cholic acid 7-sulfate and uses thereof
Engineered proteins for treatment of pancreatitis
- WO2022235551Protein drugs for pancreatitis
Evaluating splicing modulators for therapeutic impact in cohesin-mutant AML and MDS cells
- WO2023147400Compositions and Methods for Inhibiting STAG1 Expression and Uses Thereof
Evaluating splicing modulators for therapeutic impact in cohesin-mutant AML and MDS cells
- WO2023147400Compositions and methods for inhibiting STAG1 expression and uses thereof
Gene therapy for the treatment of Wolfram Syndrome II
- WO2021222476DAEUS: a high effciency gene delivery system for overexpression of geroprotective genes
- 17/743,444High efficiency purification of divergent AAV serotypes using AAVX affinity chromatography
Identification of small molecule binders of the novel cancer immunotherapy target Bird33
- WO2024050426Methods and compositions for treating cancers by modulating the expression and/or activity of STUB1
Identifying novel therapeutic targets for treating pain and chronic itch
- US20210356455A1G-protein-coupled receptors (GPCRs) regulating; somatosensation from single-cell transcriptome atlas
Isoguvacine and benzodiazepine derivatives for the treatment of tactile hypersensitivity and anxiety in autism spectrum disorders
- WO2017214442Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, Rett syndrome, and Fragile X syndrome
- WO2019232046Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
- WO2019226808Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
- WO2020198275Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
- WO2020237043Human tactile prepulse inhibition assay
Manipulating mitobiogenesis by targeting ME2
- WO2022197978Compositions and Methods for Modulating Mitochondrial Function and Biogenesis
Methods and applications of semi-permeable capsules with current application to high-throughput single cell multi-omics
- WO2024030526Core-shell capsules and uses thereof
Multiplex editing the human genome
- WO2020180975Highly multipexed genome editing
Next-generation AAV therapies for management of intractable chronic pain
- WO2020118012A scalable platform for the development of cell-type-specific viruses
- WO2023092055Nociceptor-specific gene regulatory elements for the treatment of pain
Small molecule modulators of gut bacterial bile acid metabolism to treat metabolic syndrome and associated non-alcoholic fatty liver disease (NAFLD)
- WO2020231776Small molecule modulators of gut bacterial bile acid metabolism
Studies on immunogenic lipids from the gut microbiome
- WO2023141470Immunomodulatory lipids and uses thereof
Targeting apoptotic pathways for ALS, Alzheimer’s Disease and Parkinson’s Disease
- WO2024259383Ion channel binders and uses thereof
Targeting neuro-immune signaling to treat bacterial infections
- WO2018236873Methods and compositions for treating a microbial infection